Commercial Cell Therapy Experience using Mycoplasma Nucleic Acid Testing for Product Release: Five-Year Review

Previously Aired on October 28th, 2021

Sign Up:

(*) denotes required form field(s)

Our registration process uses cookies, by submitting this registration form you agree to our cookie policy.

  Register

Overview

This webinar will provide a review of validation strategies and implementation for a rapid at-line Mycoplasma test for cell therapy companies.

You will learn:

  • The current state of Mycoplasma testing in the cell therapy field
  • How a commercial cell therapy company has implemented Mycoplasma testing based on Nucleic Acid Testing
  • The decision-making process behind using the BIOFIRE Mycoplasma platform
Who should attend:
  • QA/QC
  • Lab Directors
  • Sr. Management titles within ATMP
  • Cell & Gene Therapy
  • Bio-production segments

Presenters

Presenter
John Duguid
(Presenter)
Senior Director, Research & Development,
Vericel Corporation
View Biography
Presenter
Derek Jacobs
(Presenter)
Product Manager, BIOFIRE Mycoplasma
bioMérieux
View Biography
Presenter
Mike Auerbach
(Moderator)
Editor-in-Chief,
American Pharmaceutical Review